Fisetin and Quercetin: Uses, Evidence and What to Avoid
Partager
Fisetin and quercetin are two related plant flavonols. Both are studied as senolytics, compounds that may help clear senescent (ageing) cells. The evidence comes mostly from cell and animal work. Human data is limited to small pilot studies. They are not interchangeable, and quercetin in particular can interact with prescription medicines. This guide sets out what is known, how the two compare, and what to check before combining them.
TL;DR
- Fisetin and quercetin are flavonols found in foods such as strawberries, apples and onions. Both show senolytic activity in preclinical studies.
- Human evidence is early. A 2024 fisetin pilot study showed mixed results in biological age markers.
- Researchers test both in intermittent, high-dose cycles, not as a daily routine.
- Quercetin can interact with medicines such as warfarin. Speak to a GP or pharmacist before use if you take prescription drugs.
- Absorption differs between products, so milligrams on the label do not tell the whole story.
Table of Contents
- What fisetin and quercetin are
- What the human evidence shows
- Cycles or daily use?
- Fisetin and quercetin together: the stack question
- Interactions and what not to combine
- How to choose a product
- Our perspective
- Our fisetin and quercetin
- FAQ
- Sources
What fisetin and quercetin are
Both compounds belong to the flavonoid family. Fisetin is found in strawberries, quercetin in apples and onions. Both have antioxidant properties and both have been described as senolytic in preclinical research.
Senescent cells stop dividing but stay in tissue. They accumulate with age and release inflammatory signals. A review of senolytic drugs lists dasatinib, quercetin, fisetin and navitoclax as the first senolytics discovered. The idea behind senolytics is to remove these cells selectively.
The two molecules differ in structure and behaviour. Fisetin is often described as the stronger senolytic in laboratory comparisons. Quercetin is better studied in humans, mainly in combination with the cancer drug dasatinib. That combination is a medical research protocol, not a food supplement.

What the human evidence shows
The gap between animal results and human results is the central point.
Quercetin
Human trials have used dasatinib plus quercetin (D+Q), not quercetin alone. Small pilot studies in idiopathic pulmonary fibrosis and diabetic kidney disease reported feasibility and safety, with some signals in function and senescent cell markers. A randomised pilot trial in idiopathic pulmonary fibrosis assessed feasibility and tolerability. These were not designed as definitive efficacy trials.
The doses were also intermittent. The trial doses were typically 100 mg dasatinib with 1000 to 1250 mg quercetin, given three days a week for three weeks. That is not a pattern of daily maintenance.

Fisetin
A 2024 pilot study on fisetin and biological ageing used 500 mg daily for one week per month. Some participants improved on the biological age test. Others showed an increase. The authors’ own conclusion is that larger studies are needed before routine use can be recommended. A summary of the study notes that it had no control group.
The honest reading: both compounds are interesting, neither has proven anti-ageing effects in people.
Cycles or daily use?
Senolytics are described as acting in a hit-and-run way. The aim is to clear damaged cells with a short, intense exposure, then leave a recovery period. This is why researchers and practitioners separate senolytic protocols from daily maintenance supplements, and urge caution about chronic high-dose use without a medical reason.
| Intermittent cycle | Daily low dose | |
|---|---|---|
| Idea | Short, high exposure, then a break | Steady lower exposure |
| Reference points | Animal protocols (for example 20 mg/kg fisetin); human pilot of 500 mg for a week each month | Typical capsule doses of 100 to 200 mg |
| Evidence in humans | Small pilots, mixed results | Very limited |
| Main concern | Unknown effects of high doses without supervision | Unclear whether it does anything senolytic |
Animal doses such as 20 mg/kg do not translate directly to people. For a closer look at how the two approaches compare, see our article on fisetin dosing, cycles versus daily use.
Fisetin and quercetin together: the stack question
Many readers search for the best combination. A few points help when you assess one.
- There is no validated human stack. The human trials of quercetin used dasatinib. A pilot summary reports that adding fisetin to D+Q did not lower biological age in one small study.
- Ratios on labels are marketing choices. Equal parts of each is common, but no trial supports a particular ratio in a supplement.
- Combining raises the interaction question. Quercetin is the compound with the stronger documented interaction record, so adding it increases what you need to check.
- Separate products give control. Taking each on its own lets you adjust, pause or stop one without the other.
For these reasons we sell fisetin and quercetin as individual products rather than a fixed blend.
Interactions and what not to combine
This is the part to read before buying. The data below concerns quercetin, which has the better documented interaction profile. Fisetin has less human interaction data, which is not the same as no interactions.
Warfarin and other anticoagulants
Quercetin is a potent inhibitor of CYP2C9 and can displace warfarin from serum albumin. Warfarin is a narrow-margin medicine. If you take it, or any blood thinner, speak to your GP, thrombosis service or pharmacist before taking quercetin or fisetin.
Painkillers such as diclofenac
In a study of 12 healthy volunteers, quercetin 500 mg twice daily changed the pharmacokinetics of diclofenac sodium beyond the standard no-effect limits. If you take anti-inflammatory painkillers regularly, ask your pharmacist.
Other prescription medicines
Quercetin also affects the OATP transporter and other metabolic enzymes, which may alter how some drugs are absorbed. A safety review of quercetin as a supplement is a useful starting point for your pharmacist or doctor.
A practical checklist
- Take a list of your medicines and supplements to the pharmacist and ask specifically about flavonoids.
- Be cautious if you take anticoagulants, regular painkillers or any drug with a narrow dose range.
- Do not run high-dose cycles without medical advice, particularly if you are over 65, have kidney or liver conditions or are being treated for cancer.
- Do not take either compound as a substitute for treatment.
- Stop and speak to a doctor if you notice anything unusual after starting.
How to choose a product
A label shows the dose, but absorption decides how much reaches the blood.
- Absorption. Standard fisetin and quercetin are poorly absorbed. Some products use liposomal or phytosome delivery to improve this. One analysis reports that a gel-encapsulated fisetin formulation raised blood exposure about 27-fold, so equal milligrams in two products are not equivalent.
- Purity and testing. Look for stated purity and third-party testing.
- Clear formulation. The label should list the active, the amount per capsule and any excipients.
- Diet suitability. Check for vegan capsules and the absence of unnecessary additives.
- Dose per capsule. Lower per-capsule doses allow you to adjust. Fixed high-dose blends do not.
Our perspective
We sell both compounds, and we think the useful position is a modest one. The research is promising and unfinished. We would rather a customer understand that than buy on the promise of reversing age.
We keep fisetin and quercetin as separate products so you decide what to take and when. We publish clear formulations: our supplements are vegan, GMO-free and assembled in the Netherlands, and the range is built around ingredients with published research behind them. We do not suggest that any of them replaces medical care.
Our advice to new customers is simple. Start with one compound. Read the interaction section above. If you take medicines, ask your pharmacist first. Treat cycles as something to discuss with a professional, not something to copy from an animal study.
— Jord
Our fisetin and quercetin
Our Vivetus® Fisetin, 60 capsules of 200 mg is available as a single-ingredient capsule. Vivetus® Quercetin is sold separately. You can also see the wider fisetin collection. Orders over €50 ship free, and subscription purchase is available.
If you are building a broader routine, our guides on evidence-backed supplements for graceful ageing and on how scientific evidence supports supplement choices after 50 explain how we weigh the research.
FAQ
Which is better, fisetin or quercetin?
Neither has been shown to be better in people. Fisetin looks stronger as a senolytic in laboratory comparisons, while quercetin has more human data, mostly together with dasatinib. The choice depends on your goal, your medicines and your tolerance.
What should I not take with fisetin?
Human interaction data for fisetin is limited, so caution is sensible. Quercetin has documented interactions with warfarin and diclofenac. Anyone on anticoagulants or other prescription medicines should ask a pharmacist or GP before starting either.
Can I take fisetin and quercetin together?
Some products combine them, but no human trial supports a specific combination or ratio. Taking them separately lets you adjust each one. If you take medicines, check with a pharmacist first.
Should I take them every day?
Research protocols use intermittent, high-dose cycles rather than daily use, and practitioners urge caution about chronic high doses without a medical reason. Daily use at low doses has very little human research. Discuss your plan with a healthcare professional.
Sources
- Comprehensive Scientific Review of Supplements, Jenny Kraft
- The Effects of Fisetin on Reducing Biological Aging: A Pilot Study
- Fisetin as a Senolytic Therapy, Evipedia
- Senolytic drugs: from discovery to translation
- Senolytics in idiopathic pulmonary fibrosis, first-in-human pilot study
- Dasatinib plus quercetin in diabetic kidney disease, preliminary report
- Dasatinib and quercetin in idiopathic pulmonary fibrosis, randomised pilot trial
- Interaction of quercetin and its metabolites with warfarin
- Effect of quercetin on CYP2C9 activity of diclofenac in healthy volunteers
- Safety Aspects of the Use of Quercetin as a Dietary Supplement
